Analyst Recommendations for Amgen in February 2018
After 4Q17, Amgen (AMGN) anticipates its net revenues for 2018 to be $21.8 billion–$22.8 billion. It expects non-GAAP (generally accepted accounting principles) to be $12.60–$13.70 and its tax rate to be 14%–15%. Amgen estimated capital expenditure for 2018 of $750 million.